Ashley Revisited: A Response to the Critics

被引:31
作者
Diekema, Douglas S. [1 ]
Fost, Norman [2 ]
机构
[1] Univ Washington, Sch Med, Seattle, WA 98195 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA
关键词
cognitive impairment; developmental disability; estrogen; ethics; growth; handicapped; puberty; GROWTH ATTENUATION; ESTROGEN-TREATMENT; TALL GIRLS; DISABILITY; CHILDREN; MANAGEMENT;
D O I
10.1080/15265160903469336
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The case of Ashley X involved a young girl with profound and permanent developmental disability who underwent growth attenuation using high-dose estrogen, a hysterectomy, and surgical removal of her breast buds. Many individuals and groups have been critical of the decisions made by Ashley's parents, physicians, and the hospital ethics committee that supported the decision. While some of the opposition has been grounded in distorted facts and misunderstandings, others have raised important concerns. The purpose of this paper is to provide a brief review of the case and the issues it raised, then address 25 distinct substantive arguments that have been proposed as reasons that Ashley's treatment might be unethical. We conclude that while some important concerns have been raised, the weight of these concerns is not sufficient to consider the interventions used in Ashley's case to be contrary to her best interests, nor are they sufficient to preclude similar use of these interventions in the future for carefully selected patients who might also benefit from them.
引用
收藏
页码:30 / 44
页数:15
相关论文
共 68 条
[1]  
*AAIDD, 2007, BOARD POS STAT GROWT
[2]   The disability paradox: high quality of life against all odds [J].
Albrecht, GL ;
Devlieger, PJ .
SOCIAL SCIENCE & MEDICINE, 1999, 48 (08) :977-988
[3]  
[Anonymous], 2008, MERRIAM WEBSTER ON L
[4]  
*ASHL PAR, 2006, ASHL TREATM BETT QUA
[5]   Clinical management of menstruation in adolescent females with developmental delay [J].
Backeljauw, PF ;
Rose, SR ;
Lawson, M .
ENDOCRINOLOGIST, 2004, 14 (02) :87-92
[6]  
BAILEY JD, 1981, PEDIATR CLIN N AM, V28, P501
[7]  
Barnard Neal D, 2002, J Pediatr Adolesc Gynecol, V15, P23, DOI 10.1016/S1083-3188(01)00135-8
[8]  
BENNETT S, 2007, UCP ARC ISSUE JOINT
[9]   Growth attenuation: Unjustifiable non-therapy [J].
Bersani, Hank .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05) :520-521
[10]  
Bersani H, 2007, INTELLECT DEV DISAB, V45, P351, DOI 10.1352/0047-6765(2007)45[351:UNRTTI]2.0.CO